Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
21
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dake Benjamin T | See Remarks | 250 | $0 | $8.16M | 2024-08-01 |
| Shah Rajeev M. | Director, 10% Owner | 9 | $40.55M | $0 | 2024-06-17 |
| Verwijs Marinus | Senior Vice President, CMC | 18 | $0 | $646.9K | 2024-06-14 |
| Eldridge George A | See Remarks | 67 | $0 | $2.68M | 2024-06-14 |
| Gillies Hunter | Chief Medical Officer | 67 | $0 | $1.56M | 2024-06-13 |
| RA Capital Nexus Fund, L.P. | Director, 10% Owner | 1 | $0 | $0 | 2024-06-05 |
| GRAYZEL DAVID S. | Director | 14 | $7.50M | $334.5K | 2024-06-05 |
| Katabi Maha | Director, 10% Owner | 13 | $5.00M | $0 | 2024-06-05 |
| Resnick Joshua | Director | 4 | $0 | $0 | 2024-06-05 |
| Dable Habib J | Director | 4 | $0 | $0 | 2024-06-05 |
| Dorval Allison | Director | 4 | $0 | $0 | 2024-06-05 |
| Iwicki Mark T | Director | 6 | $0 | $0 | 2024-06-05 |
| Santel Donald J | Director | 5 | $0 | $0 | 2024-06-05 |
| NOYES TIMOTHY P | Chief Executive Officer | 63 | $0 | $3.37M | 2024-05-16 |
| NIVEN RALPH | Chief Scientific Officer | 143 | $0 | $989.3K | 2024-02-05 |
| Pigot Timothy | CHIEF COMMERCIAL OFFICER | 1 | $0 | $0 | 2024-01-22 |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 1 | $0 | $0 | 2023-06-06 |
| Atlas Venture Fund XII, L.P. | 10% Owner | 5 | $7.50M | $0 | 2022-07-15 |
| Kolchinsky Peter | Director, 10% Owner | 1 | $0 | $0 | 2022-06-21 |
| Sofinnova Venture Partners X, L.P. | 10% Owner | 3 | $5.00M | $0 | 2021-07-02 |
| Cormorant Global Healthcare Master Fund, LP | Other | 3 | $7.00M | $0 | 2021-07-02 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-08-01 | 2024-08-02 | 1,507 | — | $0 | 0 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-08-01 | 2024-08-02 | 1,507 | $1.74 | $2.6K | 14,252 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-07-31 | 2024-08-02 | 10,548 | — | $0 | 1,507 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-07-31 | 2024-08-02 | 906 | — | $0 | 0 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-07-31 | 2024-08-02 | 11,454 | $1.74 | $19.9K | 12,745 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | P Buy | 2024-06-17 | 2024-06-20 | 928,110 | $1.67 | $1.55M | 7,893,678 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise deriv | 2024-06-14 | 2024-06-14 | 10,600 | — | $0 | 68,800 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-06-14 | 2024-06-14 | 15,000 | — | $0 | 28,763 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise | 2024-06-14 | 2024-06-14 | 10,600 | $14.59 | $154.7K | 10,600 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-06-14 | 2024-06-14 | 10,600 | $25.00 | $265.0K | 0 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-06-14 | 2024-06-14 | 15,000 | $2.14 | $32.1K | 20,022 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-06-14 | 2024-06-14 | 15,000 | $25.03 | $375.4K | 5,022 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-06-13 | 2024-06-14 | 6,000 | — | $0 | 83,510 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-06-13 | 2024-06-14 | 6,000 | $2.14 | $12.8K | 11,602 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-06-13 | 2024-06-14 | 6,000 | $24.50 | $147.0K | 5,602 | SEC↗ |
| Dorval Allison | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GRAYZEL DAVID S. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Katabi Maha | Director, 10% Owner | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Santel Donald J | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director, 10% Owner | A Award deriv | 2024-06-05 | 2024-06-07 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-05-17 | 2024-05-17 | 4,000 | — | $0 | 11,324 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-05-17 | 2024-05-17 | 4,000 | $2.14 | $8.6K | 9,602 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-05-17 | 2024-05-17 | 3,914 | $21.07 | $82.5K | 5,688 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-05-17 | 2024-05-17 | 86 | $21.86 | $1.9K | 5,602 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-05-16 | 2024-05-17 | 10,000 | — | $0 | 343,381 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-05-16 | 2024-05-17 | 8,707 | $21.52 | $187.4K | 1,293 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-05-16 | 2024-05-17 | 1,293 | $21.92 | $28.3K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-05-16 | 2024-05-17 | 10,000 | $2.14 | $21.4K | 10,000 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-05-02 | 2024-05-03 | 1,981 | $21.02 | $41.6K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-05-01 | 2024-05-03 | 10,000 | — | $0 | 353,381 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-05-01 | 2024-05-03 | 1,357 | $19.91 | $27.0K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-05-01 | 2024-05-03 | 965 | $20.87 | $20.1K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-05-01 | 2024-05-03 | 9,035 | $20.34 | $183.8K | 965 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-05-01 | 2024-05-03 | 10,000 | $2.14 | $21.4K | 10,000 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-04-17 | 2024-04-19 | 503 | — | $0 | 2,511 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-04-17 | 2024-04-19 | 3,497 | — | $0 | 539 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-04-17 | 2024-04-19 | 6,853 | — | $0 | 95,936 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-04-17 | 2024-04-19 | 3,689 | $22.30 | $82.3K | 3,562 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-04-17 | 2024-04-19 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-04-17 | 2024-04-19 | 311 | $23.33 | $7.3K | 3,251 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-04-17 | 2024-04-19 | 6,853 | $2.14 | $14.7K | 8,144 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-04-17 | 2024-04-19 | 338 | $23.17 | $7.8K | 1,359 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-04-17 | 2024-04-19 | 68 | $23.97 | $1.6K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-04-17 | 2024-04-19 | 6,447 | $22.32 | $143.9K | 1,697 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-04-16 | 2024-04-18 | 10,000 | — | $0 | 363,381 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-04-16 | 2024-04-18 | 10,000 | $2.14 | $21.4K | 10,000 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-16 | 2024-04-18 | 4,491 | $24.40 | $109.6K | 5,509 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-16 | 2024-04-18 | 5,509 | $24.94 | $137.4K | 0 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-04-10 | 2024-04-12 | 7,500 | — | $0 | 43,763 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-04-10 | 2024-04-12 | 7,500 | $2.14 | $16.1K | 9,460 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-04-10 | 2024-04-12 | 6,729 | $26.77 | $180.1K | 2,731 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-04-10 | 2024-04-12 | 771 | $27.56 | $21.2K | 1,960 | SEC↗ |
| GRAYZEL DAVID S. | Director | S Sale | 2024-04-09 | 2024-04-11 | 11,882 | $28.15 | $334.5K | 14,502 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-04-01 | 2024-04-03 | 12,495 | — | $0 | 15,768 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-04-01 | 2024-04-03 | 3,325 | — | $0 | 25,675 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 10,000 | — | $0 | 373,381 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise deriv | 2024-04-01 | 2024-04-03 | 5,300 | — | $0 | 79,400 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-04-01 | 2024-04-03 | 12,495 | $31.23 | $390.2K | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-04-01 | 2024-04-03 | 12,495 | $2.14 | $26.7K | 14,455 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-04-01 | 2024-04-03 | 3,325 | $10.61 | $35.3K | 4,616 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-04-01 | 2024-04-03 | 3,325 | $31.97 | $106.3K | 1,291 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 1,647 | $29.90 | $49.2K | 3,851 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 4,502 | $28.96 | $130.4K | 5,498 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 10,000 | $2.14 | $21.4K | 10,000 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 1,000 | $31.95 | $31.9K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 2,851 | $31.02 | $88.4K | 1,000 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise | 2024-04-01 | 2024-04-03 | 5,300 | $14.59 | $77.3K | 5,300 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 1,504 | $30.00 | $45.1K | 0 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-04-01 | 2024-04-03 | 3,796 | $28.87 | $109.6K | 1,504 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-03-28 | 2024-04-01 | 9,000 | — | $0 | 89,510 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-03-28 | 2024-04-01 | 9,000 | $2.14 | $19.3K | 12,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-03-28 | 2024-04-01 | 9,000 | $29.50 | $265.5K | 3,251 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-03-27 | 2024-03-28 | 11,068 | — | $0 | 29,000 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-03-27 | 2024-03-28 | 11,068 | $27.97 | $309.6K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-03-27 | 2024-03-28 | 11,068 | $10.61 | $117.4K | 12,359 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-03-25 | 2024-03-27 | 3,432 | — | $0 | 40,068 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-03-25 | 2024-03-27 | 3,432 | $28.01 | $96.1K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-03-25 | 2024-03-27 | 3,432 | $10.61 | $36.4K | 4,723 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise deriv | 2024-03-19 | 2024-03-20 | 5,300 | — | $0 | 84,700 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-03-19 | 2024-03-20 | 2,764 | $26.46 | $73.1K | 0 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | M Exercise | 2024-03-19 | 2024-03-20 | 5,300 | $14.59 | $77.3K | 5,300 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNICAL OFFICER | S Sale | 2024-03-19 | 2024-03-20 | 2,536 | $25.68 | $65.1K | 2,764 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-03-18 | 2024-03-20 | 20,557 | — | $0 | 102,789 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2024-03-18 | 2024-03-20 | 14,500 | — | $0 | 43,500 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-03-18 | 2024-03-20 | 3,000 | — | $0 | 98,510 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-03-18 | 2024-03-20 | 4,000 | — | $0 | 4,036 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-03-18 | 2024-03-20 | 20,557 | $2.14 | $44.0K | 21,848 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2024-03-18 | 2024-03-20 | 14,500 | $10.61 | $153.8K | 36,348 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-03-18 | 2024-03-20 | 27,476 | $25.74 | $707.2K | 8,872 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2024-03-18 | 2024-03-20 | 7,581 | $26.48 | $200.7K | 1,291 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-03-18 | 2024-03-20 | 613 | $26.40 | $16.2K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-03-18 | 2024-03-20 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-03-18 | 2024-03-20 | 3,000 | $2.14 | $6.4K | 10,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-03-18 | 2024-03-20 | 6,387 | $25.81 | $164.8K | 3,864 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-13 | 2024-03-14 | 2,016 | — | $0 | 51,263 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-03-13 | 2024-03-14 | 2,016 | $2.14 | $4.3K | 3,976 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-13 | 2024-03-14 | 2,016 | $25.02 | $50.4K | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-12 | 2024-03-14 | 2,051 | — | $0 | 53,279 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-03-12 | 2024-03-14 | 2,051 | $2.14 | $4.4K | 4,011 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-12 | 2024-03-14 | 2,051 | $25.05 | $51.4K | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-11 | 2024-03-11 | 3,433 | — | $0 | 55,330 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-03-11 | 2024-03-11 | 3,433 | $2.14 | $7.3K | 5,393 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-11 | 2024-03-11 | 10 | $26.31 | $263 | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-11 | 2024-03-11 | 3,423 | $25.24 | $86.4K | 1,970 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-08 | 2024-03-11 | 114 | — | $0 | 58,763 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-08 | 2024-03-11 | 114 | $25.00 | $2.9K | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-03-08 | 2024-03-11 | 114 | $2.14 | $244 | 2,074 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-03-07 | 2024-03-11 | 8,030 | — | $0 | 101,510 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-03-07 | 2024-03-11 | 945 | — | $0 | 15,324 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-07 | 2024-03-11 | 20,986 | — | $0 | 58,877 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise deriv | 2024-03-07 | 2024-03-11 | 1,400 | — | $0 | 28,263 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-03-07 | 2024-03-11 | 8,975 | $2.14 | $19.2K | 12,226 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-03-07 | 2024-03-11 | 8,975 | $24.50 | $219.9K | 3,251 | SEC↗ |
| Eldridge George A | SEE REMARKS | S Sale | 2024-03-07 | 2024-03-11 | 22,386 | $25.00 | $559.6K | 1,960 | SEC↗ |
| Eldridge George A | SEE REMARKS | M Exercise | 2024-03-07 | 2024-03-11 | 22,386 | $2.14 | $47.9K | 24,346 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2024-03-04 | 2024-03-06 | 1,531 | $16.37 | $25.1K | 1,531 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-02-23 | 2024-02-27 | 511 | — | $0 | 3,014 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-02-23 | 2024-02-27 | 511 | $19.50 | $10.0K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-02-23 | 2024-02-27 | 511 | $1.74 | $889 | 3,762 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-02-20 | 2024-02-22 | 987 | — | $0 | 8,036 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-02-20 | 2024-02-22 | 2,502 | — | $0 | 3,525 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-02-20 | 2024-02-22 | 898 | $20.58 | $18.5K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-02-20 | 2024-02-22 | 3,489 | $1.74 | $6.1K | 6,740 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-02-20 | 2024-02-22 | 2,591 | $20.11 | $52.1K | 4,149 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-02-05 | 2024-02-07 | 900 | — | $0 | 13,308 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-02-05 | 2024-02-07 | 500 | — | $0 | 10,894 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-02-05 | 2024-02-07 | 500 | — | $0 | 9,088 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-02-05 | 2024-02-07 | 1,200 | — | $0 | 34,908 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-02-05 | 2024-02-07 | 1,500 | — | $0 | 41,732 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-02-05 | 2024-02-07 | 3,200 | $2.14 | $6.8K | 6,209 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-02-05 | 2024-02-07 | 4,600 | $17.45 | $80.3K | 1,609 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-02-05 | 2024-02-07 | 1,400 | $1.74 | $2.4K | 3,009 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-01-29 | 2024-01-31 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Eldridge George A | SEE REMARKS | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNOLOGY OFFICER | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| Pigot Timothy | CHIEF COMMERCIAL OFFICER | A Award deriv | 2024-01-22 | 2024-01-24 | 66,586 | — | $0 | 66,586 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2024-01-17 | 2024-01-19 | 4,000 | — | $0 | 6,027 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2024-01-17 | 2024-01-19 | 4,000 | $19.50 | $78.0K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2024-01-17 | 2024-01-19 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-01-05 | 2024-01-08 | 1,200 | — | $0 | 36,108 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-01-05 | 2024-01-08 | 1,500 | — | $0 | 43,232 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-01-05 | 2024-01-08 | 900 | — | $0 | 14,208 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-01-05 | 2024-01-08 | 500 | — | $0 | 9,588 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2024-01-05 | 2024-01-08 | 500 | — | $0 | 11,394 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-01-05 | 2024-01-08 | 2,474 | $19.57 | $48.4K | 1,609 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2024-01-05 | 2024-01-08 | 2,126 | $18.67 | $39.7K | 4,083 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-01-05 | 2024-01-08 | 3,200 | $2.14 | $6.8K | 6,209 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2024-01-05 | 2024-01-08 | 1,400 | $1.74 | $2.4K | 3,009 | SEC↗ |
| GRAYZEL DAVID S. | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 3,186 | $13.49 | $43.0K | 3,186 | SEC↗ |
| Katabi Maha | Director, 10% Owner | A Award deriv | 2024-01-02 | 2024-01-04 | 3,519 | $13.49 | $47.5K | 3,519 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 2,964 | $13.49 | $40.0K | 2,964 | SEC↗ |
| Santel Donald J | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 2,889 | $13.49 | $39.0K | 2,889 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-27 | 2023-12-29 | 25 | — | $0 | 16,269 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-27 | 2023-12-29 | 100 | — | $0 | 109,540 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-12-27 | 2023-12-29 | 125 | $2.14 | $268 | 3,376 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-12-27 | 2023-12-29 | 125 | $24.50 | $3.1K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-20 | 2023-12-22 | 2,924 | — | $0 | 9,023 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-20 | 2023-12-22 | 1,076 | — | $0 | 10,027 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-12-20 | 2023-12-22 | 4,000 | $19.50 | $78.0K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-14 | 2023-12-15 | 2,700 | — | $0 | 12,744 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-14 | 2023-12-15 | 7,197 | — | $0 | 10,306 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-12-14 | 2023-12-15 | 9,897 | $19.50 | $193.0K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-12-14 | 2023-12-15 | 9,897 | $1.74 | $17.2K | 13,148 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-13 | 2023-12-15 | 1,450 | — | $0 | 17,503 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-12-13 | 2023-12-15 | 653 | — | $0 | 15,444 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-12-13 | 2023-12-15 | 2,103 | $1.74 | $3.7K | 5,354 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-12-13 | 2023-12-15 | 2,103 | $19.50 | $41.0K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-12-13 | 2023-12-22 | 4,000 | $1.74 | $7.0K | 7,251 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-12-06 | 2023-12-07 | 905 | — | $0 | 906 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-12-06 | 2023-12-07 | 1,506 | — | $0 | 12,055 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-12-06 | 2023-12-07 | 6,853 | — | $0 | 123,346 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-12-06 | 2023-12-07 | 1,019 | — | $0 | 16,294 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-12-06 | 2023-12-07 | 10,283 | $16.11 | $165.7K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-12-06 | 2023-12-07 | 7,872 | $2.14 | $16.8K | 11,574 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-12-06 | 2023-12-07 | 2,411 | $1.74 | $4.2K | 3,702 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-12-05 | 2023-12-07 | 1,200 | — | $0 | 37,308 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-12-05 | 2023-12-07 | 500 | — | $0 | 10,088 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-12-05 | 2023-12-07 | 500 | — | $0 | 11,894 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-12-05 | 2023-12-07 | 1,500 | — | $0 | 44,732 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-12-05 | 2023-12-07 | 900 | — | $0 | 15,108 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-12-05 | 2023-12-07 | 4,600 | $16.30 | $75.0K | 1,609 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-12-05 | 2023-12-07 | 1,400 | $1.74 | $2.4K | 3,009 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-12-05 | 2023-12-07 | 3,200 | $2.14 | $6.8K | 6,209 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-27 | 2023-11-29 | 906 | — | $0 | 1,811 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-27 | 2023-11-29 | 9,086 | — | $0 | 130,199 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-27 | 2023-11-29 | 1,018 | — | $0 | 17,313 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-27 | 2023-11-29 | 1,507 | — | $0 | 13,561 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-11-27 | 2023-11-29 | 12,517 | $16.24 | $203.3K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-11-27 | 2023-11-29 | 2,413 | $1.74 | $4.2K | 3,704 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-11-27 | 2023-11-29 | 10,104 | $2.14 | $21.6K | 13,808 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-24 | 2023-11-27 | 371 | — | $0 | 18,331 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-24 | 2023-11-27 | 4,619 | — | $0 | 139,285 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-11-24 | 2023-11-27 | 4,990 | $2.14 | $10.7K | 6,281 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-11-24 | 2023-11-27 | 70 | $16.07 | $1.1K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-11-24 | 2023-11-27 | 4,920 | $15.74 | $77.4K | 1,361 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-11-22 | 2023-11-27 | 4,500 | — | $0 | 46,232 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-11-22 | 2023-11-27 | 3,600 | — | $0 | 38,508 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-11-22 | 2023-11-27 | 1,500 | — | $0 | 12,394 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-11-22 | 2023-11-27 | 1,500 | — | $0 | 10,588 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-11-22 | 2023-11-27 | 2,700 | — | $0 | 16,008 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-22 | 2023-11-27 | 1,507 | — | $0 | 15,068 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-22 | 2023-11-27 | 905 | — | $0 | 2,717 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-22 | 2023-11-27 | 648 | — | $0 | 18,702 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-11-22 | 2023-11-27 | 6,322 | — | $0 | 143,904 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-11-22 | 2023-11-27 | 13,800 | $15.00 | $207.0K | 1,609 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-11-22 | 2023-11-27 | 4,200 | $1.74 | $7.3K | 5,809 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-11-22 | 2023-11-27 | 9,600 | $2.14 | $20.5K | 15,409 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-11-22 | 2023-11-27 | 9,382 | $15.17 | $142.3K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-11-22 | 2023-11-27 | 6,970 | $2.14 | $14.9K | 10,673 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-11-22 | 2023-11-27 | 2,412 | $1.74 | $4.2K | 3,703 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2023-11-01 | 2023-11-03 | 1,092 | $10.42 | $11.4K | 0 | SEC↗ |
| Verwijs Marinus | CHIEF TECHNOLOGY OFFICER | S Sale | 2023-11-01 | 2023-11-03 | 970 | $10.46 | $10.1K | 0 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-09-07 | 2023-09-08 | 30 | — | $0 | 150,226 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-09-07 | 2023-09-08 | 30 | $2.14 | $64 | 1,321 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-09-07 | 2023-09-08 | 30 | $15.01 | $450 | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-09-06 | 2023-09-08 | 906 | — | $0 | 3,622 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-09-06 | 2023-09-08 | 1,507 | — | $0 | 16,575 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-09-06 | 2023-09-08 | 1,018 | — | $0 | 19,350 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-09-06 | 2023-09-08 | 500 | — | $0 | 150,256 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-09-06 | 2023-09-08 | 2,413 | $1.74 | $4.2K | 3,704 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-09-06 | 2023-09-08 | 1,518 | $2.14 | $3.2K | 5,222 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-09-06 | 2023-09-08 | 3,931 | $15.06 | $59.2K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-08-07 | 2023-08-09 | 6,853 | — | $0 | 150,756 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-08-07 | 2023-08-09 | 1,018 | — | $0 | 20,368 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-08-07 | 2023-08-09 | 905 | — | $0 | 4,528 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-08-07 | 2023-08-09 | 1,507 | — | $0 | 18,082 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-08-07 | 2023-08-09 | 541 | $16.25 | $8.8K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-08-07 | 2023-08-09 | 9,742 | $15.48 | $150.8K | 1,832 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-08-07 | 2023-08-09 | 7,871 | $2.14 | $16.8K | 11,574 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-08-07 | 2023-08-09 | 2,412 | $1.74 | $4.2K | 3,703 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-07-28 | 2023-08-01 | 5,478 | — | $0 | 383,381 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2023-07-28 | 2023-08-01 | 5,478 | $18.00 | $98.6K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-07-28 | 2023-08-01 | 5,478 | $2.14 | $11.7K | 5,478 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-07-17 | 2023-07-19 | 4,522 | — | $0 | 388,859 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-07-17 | 2023-07-19 | 4,522 | $2.14 | $9.7K | 4,522 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2023-07-17 | 2023-07-19 | 4,522 | $18.11 | $81.9K | 0 | SEC↗ |
| Dable Habib J | Director | A Award deriv | 2023-07-10 | 2023-07-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-07-06 | 2023-07-07 | 1,506 | — | $0 | 19,589 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-07-06 | 2023-07-07 | 906 | — | $0 | 5,433 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-07-06 | 2023-07-07 | 1,019 | — | $0 | 21,386 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-07-06 | 2023-07-07 | 6,852 | — | $0 | 157,609 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-07-06 | 2023-07-07 | 10,283 | $16.66 | $171.3K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-07-06 | 2023-07-07 | 7,871 | $2.14 | $16.8K | 11,574 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-07-06 | 2023-07-07 | 2,412 | $1.74 | $4.2K | 3,703 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-07-05 | 2023-07-07 | 750 | — | $0 | 50,732 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-07-05 | 2023-07-07 | 450 | — | $0 | 18,708 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-07-05 | 2023-07-07 | 200 | — | $0 | 12,088 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-07-05 | 2023-07-07 | 200 | — | $0 | 13,894 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-07-05 | 2023-07-07 | 650 | — | $0 | 42,108 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-07-05 | 2023-07-07 | 219 | $17.87 | $3.9K | 1,609 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-07-05 | 2023-07-07 | 2,031 | $17.23 | $35.0K | 1,828 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-07-05 | 2023-07-07 | 1,600 | $2.14 | $3.4K | 3,859 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-07-05 | 2023-07-07 | 650 | $1.74 | $1.1K | 2,259 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise deriv | 2023-07-03 | 2023-07-05 | 10,000 | — | $0 | 393,381 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | S Sale | 2023-07-03 | 2023-07-05 | 10,000 | $18.00 | $180.0K | 0 | SEC↗ |
| NOYES TIMOTHY P | CHIEF EXECUTIVE OFFICER | M Exercise | 2023-07-03 | 2023-07-05 | 10,000 | $2.14 | $21.4K | 10,000 | SEC↗ |
| Dorval Allison | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Iwicki Mark T | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GRAYZEL DAVID S. | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Katabi Maha | Director, 10% Owner | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Santel Donald J | Director | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-06-06 | 2023-06-08 | 1,018 | — | $0 | 22,405 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-06-06 | 2023-06-08 | 1,507 | — | $0 | 21,095 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-06-06 | 2023-06-08 | 905 | — | $0 | 6,339 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-06-06 | 2023-06-08 | 6,853 | — | $0 | 164,461 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2023-06-06 | 2023-06-08 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-06-06 | 2023-06-08 | 7,871 | $2.14 | $16.8K | 11,574 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-06-06 | 2023-06-08 | 2,412 | $1.74 | $4.2K | 3,703 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-06-06 | 2023-06-08 | 15 | $16.98 | $255 | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-06-06 | 2023-06-08 | 10,268 | $16.28 | $167.2K | 1,306 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-06-05 | 2023-06-07 | 750 | — | $0 | 51,482 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-06-05 | 2023-06-07 | 450 | — | $0 | 19,158 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-06-05 | 2023-06-07 | 200 | — | $0 | 12,288 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-06-05 | 2023-06-07 | 200 | — | $0 | 14,094 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-06-05 | 2023-06-07 | 650 | — | $0 | 42,758 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-06-05 | 2023-06-07 | 650 | $1.74 | $1.1K | 2,259 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise | 2023-06-05 | 2023-06-07 | 1,600 | $2.14 | $3.4K | 3,859 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | S Sale | 2023-06-05 | 2023-06-07 | 2,250 | $16.26 | $36.6K | 1,609 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-05-19 | 2023-05-23 | 65 | — | $0 | 18,953 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-05-19 | 2023-05-23 | 65 | $19.50 | $1.3K | 3,251 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-05-19 | 2023-05-23 | 65 | $1.74 | $113 | 3,316 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise deriv | 2023-05-17 | 2023-05-19 | 1,090 | — | $0 | 19,018 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | M Exercise | 2023-05-17 | 2023-05-19 | 1,090 | $1.74 | $1.9K | 4,341 | SEC↗ |
| Gillies Hunter | CHIEF MEDICAL OFFICER | S Sale | 2023-05-17 | 2023-05-19 | 1,090 | $19.59 | $21.4K | 3,251 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-05-08 | 2023-05-09 | 906 | — | $0 | 7,244 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-05-08 | 2023-05-09 | 6,853 | — | $0 | 171,314 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-05-08 | 2023-05-09 | 1,018 | — | $0 | 23,423 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise deriv | 2023-05-08 | 2023-05-09 | 1,507 | — | $0 | 22,602 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-05-08 | 2023-05-09 | 1,599 | $22.74 | $36.4K | 1,291 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-05-08 | 2023-05-09 | 2,413 | $1.74 | $4.2K | 3,704 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | M Exercise | 2023-05-08 | 2023-05-09 | 7,871 | $2.14 | $16.8K | 11,575 | SEC↗ |
| Dake Benjamin T | SEE REMARKS | S Sale | 2023-05-08 | 2023-05-09 | 8,685 | $21.62 | $187.8K | 2,890 | SEC↗ |
| NIVEN RALPH | CHIEF SCIENTIFIC OFFICER | M Exercise deriv | 2023-05-05 | 2023-05-09 | 200 | — | $0 | 12,488 | SEC↗ |